Fisher Funds Management LTD Invests $5.10 Million in CVS Health Co. (NYSE:CVS)

Fisher Funds Management LTD acquired a new position in CVS Health Co. (NYSE:CVS - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 114,549 shares of the pharmacy operator's stock, valued at approximately $5,103,000.

Other institutional investors have also recently added to or reduced their stakes in the company. Integrated Advisors Network LLC grew its stake in shares of CVS Health by 0.7% in the 3rd quarter. Integrated Advisors Network LLC now owns 27,625 shares of the pharmacy operator's stock worth $1,737,000 after purchasing an additional 200 shares during the last quarter. Widmann Financial Services Inc. boosted its holdings in CVS Health by 1.8% during the third quarter. Widmann Financial Services Inc. now owns 11,506 shares of the pharmacy operator's stock worth $724,000 after buying an additional 200 shares in the last quarter. Manchester Capital Management LLC grew its position in CVS Health by 4.8% in the fourth quarter. Manchester Capital Management LLC now owns 4,457 shares of the pharmacy operator's stock worth $200,000 after buying an additional 204 shares during the last quarter. Rogco LP increased its holdings in shares of CVS Health by 3.2% in the fourth quarter. Rogco LP now owns 6,752 shares of the pharmacy operator's stock valued at $303,000 after buying an additional 210 shares in the last quarter. Finally, United Asset Strategies Inc. lifted its position in shares of CVS Health by 2.4% during the 3rd quarter. United Asset Strategies Inc. now owns 9,217 shares of the pharmacy operator's stock valued at $580,000 after acquiring an additional 212 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

Wall Street Analysts Forecast Growth

CVS has been the topic of a number of recent analyst reports. Barclays boosted their target price on CVS Health from $71.00 to $73.00 and gave the stock an "overweight" rating in a research report on Thursday, February 13th. UBS Group cut their price objective on CVS Health from $62.00 to $59.00 and set a "neutral" rating on the stock in a report on Tuesday, February 11th. Edward Jones upgraded shares of CVS Health from a "hold" rating to a "buy" rating in a report on Thursday, January 30th. Evercore ISI boosted their price target on shares of CVS Health from $60.00 to $65.00 and gave the company an "outperform" rating in a report on Monday, January 27th. Finally, Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a "hold" rating to a "buy" rating and set a $66.00 price objective for the company in a research note on Tuesday, December 3rd. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $70.00.

Insider Activity at CVS Health

In other news, Director Michael F. Mahoney bought 30,000 shares of the stock in a transaction that occurred on Tuesday, February 18th. The shares were acquired at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the purchase, the director now owns 39,356 shares of the company's stock, valued at $2,625,045.20. This represents a 320.65 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.24% of the stock is owned by company insiders.

CVS Health Stock Up 0.2 %

NYSE:CVS traded up $0.12 during mid-day trading on Wednesday, reaching $63.78. The stock had a trading volume of 6,555,320 shares, compared to its average volume of 12,721,988. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The stock has a market cap of $80.42 billion, a P/E ratio of 17.43, a PEG ratio of 0.98 and a beta of 0.61. The business's 50 day moving average is $53.11 and its 200 day moving average is $56.29. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $80.75.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating analysts' consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. As a group, sell-side analysts predict that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.17%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health's dividend payout ratio is 72.68%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.